Browsing Tag

#ILUVIEN

Alimera Announces Agreement with Jaeb Center for Health Research on Behalf of the…

Eli Pacheco Sep 23, 2022 0

ATLANTA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians…

Health

Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Ireland

Eli Pacheco Sep 20, 2022 0

ATLANTA, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians,…

Health

Alimera Announces Approval and Pricing Granted for ILUVIEN® for Uveitis in Italy

Eli Pacheco Jul 8, 2022 0

ATLANTA, July 08, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and…